Michael Hagen
About
Michael Hagen is from Detroit Metropolitan Area. Michael works in the following industries: "Pharmaceuticals". Michael is currently Senior Business Development Executive at Thermofisher Scientific, located in United States. Michael also works as Sr. Director, US Sales and Business Development at Alcami Corporation, a job Michael has held since Dec 2016. In Michael's previous role as a Director, Business Development at Ash Stevens Inc., Michael worked in 18655 Krause Street, Riverview, MI 48193 until Dec 2016. Prior to joining Ash Stevens Inc., Michael was a Director, Entrepreneurial Services—Biosciences at MICHIGAN ECONOMIC DEVELOPMENT CORPORATION and held the position of Director, Entrepreneurial Services—Biosciences at Ann Arbor, Michigan. Prior to that, Michael was a Vice President, Marketing & Sales, Western Hemisphere at APOLLO CYTOKINE RESEARCH, based in San Clemente, California from Feb 2007 to Apr 2008. Michael started working as Vice President, OEM Western Hemisphere at PALL LIFE SCIENCES in San Clemente, CA in May 2000.
Michael Hagen's contact information is available for free on finalscout.com, a web-based professional networking database with more than 500 million business contacts and 200 million company profiles.
Michael Hagen's current jobs
Work with existing and new clients by providing contract services that encompass the entire process of pharmaceutical drug development from discovery through commercialization.
Michael Hagen's past jobs
Generate new development deals for the company that focuses on pharmaceutical manufacturing services that encompasses regulatory compliance, on-schedule, and on-budget API's.
Develop and implement individualized strategies for life sciences companies considering expansion, reinvestment, or relocation throughout the State of Michigan
Developed and implemented a ‘go to market’ strategic and tactical plan to brand this Australian publicly traded company as the premier provider of human expressed cytokines in the life science market
Led and directed the business development activities of the company’s Original Equipment Manufacturers (OEM) membrane based business segment, including medical devices, diagnostics, membrane and associated components